赫兹生物科技是一家专注于纳米抗体快速筛选及医疗用途开发的全球化生物科技公司。同时也是瑞士Affinibody生物公司的中国服务中心。公司运用其拥有的全部自主知识产权的超大容量的半合成人源化纳米抗体库(>1015)及HZ纳米抗体极速筛选平台开拓新型治疗性抗体药物产品管线, 并围绕快速纳米抗体筛选技术平台拓展合作与授权业务。

H&Z LifeScience Co., Ltd is a global biotechnology company developing innovative single domain antibody therapeutics based on its patented HZ Fast Screen PlatformTM. We screen humanized single domain antibodies from a giant semi-synthetic library with size >1015 via a novel method.  The company's business is centered around its patented fast single domain antibody screening library and platforms including licensing the platforms to companies and academic institutions through its subsidiary.

中国公司运营基地位于烟台,同时分别在北京丰台及烟台高新区建立了研发中心,欧洲公司在瑞士伯尔尼。公司拥有资深管理团队以及丰富的纳米抗体研究与开发经验。

H&Z LifeScience has its operation site and development center in Yantai and Beijing, China, and Bern, Switzerland. Our management team has extensive experience in single domain antibody development and application.

赫兹生物科技为满足医疗健康行业的需求,依托自主知识产权的核心筛选平台,创建一个在纳米抗体领域有技术领导力的国际性生物医药公司。同时赫兹生物科技通过自我技术平台实现纳米抗体的批量筛选及对外开展授权合作,致力于推动中国及全球的抗体研发产业的进步。

H&Z LifeScience is building its proprietary pipeline internally and through licensed collaborations to establish its well-recognized leadership in the field of single domain antibody and make its own contribution to the development of antibody industries. 

 

 

 

技术支持:讯博网络